Zolgensma won FDA approval in May as the drugmaker was working on an internal probe over data manipulation. (Novartis) Amid a fresh scandal, this time over data ...

Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ("Ono") announced today the three companies have entered into a clinical collaborat...

Novartis will unveil details from Kisqali's latest phase 3 win at an upcoming medical meeting. (Novartis) In June, Novartis’ Kisqali showed it could prolong the ...

Eyeing Xtandi and Erleada, Bayer and Orion's Nubeqa has won FDA approval in non-metastatic castration-resistant prostate cancer market. (Bayer) Pfizer and Astell...

An experimental drug developed by Johnson & Johnson for multiple sclerosis succeeded in a head-to-head study against Sanofi's on-market therapy Aubagio, accor...

Global Blood Therapeutics has in hand positive data from a late-stage study of its sickle cell disease drug, which could be a "promising advancement" in the way t...

After decades of frustrated research efforts, enthusiasm is rising for early-stage clinical work to develop drugs that target a genetic mutation known as KRAS, an...